{"name": "Zosano Pharma",
 "permalink": "zosano-pharma",
 "crunchbase_url": "http://www.crunchbase.com/company/zosano-pharma",
 "homepage_url": "http://zosanopharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": 10,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "510-745-1200",
 "description": "Osteoporosis Treatment Research",
 "created_at": "Tue Jul 14 11:35:12 UTC 2009",
 "updated_at": "Thu Sep 24 21:30:33 UTC 2009",
 "overview": "\u003Cp\u003EZosano Pharma is a private pharmaceutical company founded in October 2006 and is focused on creating better products with their innovative drug delivery technology.  \u003C/p\u003E\n\n\u003Cp\u003ETheir lead program, parathyroid hormone (PTH) transdermal microprojection delivery system has finalized a Phase 2 clinical trial for treating severe osteoporosis.  Zosano\u00e2\u20ac\u2122s objective is to discover and develop therapeutic drug candidates which address large unmet medical needs or have a significant potential for commercialization.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       55],
      "assets/images/resized/0005/2868/52868v1-max-150x150.jpg"],
     [[250,
       92],
      "assets/images/resized/0005/2868/52868v1-max-250x250.jpg"],
     [[267,
       99],
      "assets/images/resized/0005/2868/52868v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$120M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://zosanopharma.com/index.php?option=com_content\u0026task=view\u0026id=9\u0026Itemid=93",
    "source_description": "Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million",
    "raised_amount": 90000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 11,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Nomura Phase4 Ventures",
         "permalink": "nomura-phase4-ventures",
         "image":
          {"available_sizes":
            [[[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-150x150.png"],
             [[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-250x250.png"],
             [[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ProQuest Investments",
         "permalink": "proquest-investments",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/2876/52876v1-max-150x150.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-250x250.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://onbiovc.com/zosano-pharma-inc-series-b-30m/",
    "source_description": "Zosano Pharma, Inc.: Series B $30M",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 8,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Nomura Phase4 Ventures",
         "permalink": "nomura-phase4-ventures",
         "image":
          {"available_sizes":
            [[[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-150x150.png"],
             [[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-250x250.png"],
             [[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ProQuest Investments",
         "permalink": "proquest-investments",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/2876/52876v1-max-150x150.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-250x250.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "34790 Ardentech Court ",
    "address2": "",
    "zip_code": "94555",
    "city": "Fremont",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.55175,
    "longitude": -122.058121}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        87],
       "assets/images/resized/0005/2869/52869v1-max-150x150.jpg"],
      [[250,
        145],
       "assets/images/resized/0005/2869/52869v1-max-250x250.jpg"],
      [[450,
        262],
       "assets/images/resized/0005/2869/52869v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}